NYSE:CVS - CVS Health Stock Price, Price Target & More

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Wednesday, July 11th. Stockholders of record on Wednesday, July 25th will be paid a dividend of $0.50 per share on Wednesday, August 1st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.93%. The ex-dividend date of this dividend is Tuesday, July 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its quarterly earnings data on Wednesday, May, 2nd. The pharmacy operator reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.09. The pharmacy operator had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.77 billion. CVS Health had a net margin of 3.59% and a return on equity of 17.45%. CVS Health's revenue for the quarter was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.17 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY18 earnings guidance on Wednesday, May, 2nd. The company provided earnings per share (EPS) guidance of $6.87-7.08 for the period, compared to the Thomson Reuters consensus estimate of $6.45. CVS Health also updated its Q2 guidance to $1.59-1.64 EPS.

18 equities research analysts have issued 1-year price objectives for CVS Health's shares. Their predictions range from $68.00 to $99.00. On average, they expect CVS Health's stock price to reach $86.3125 in the next year. This suggests a possible upside of 26.5% from the stock's current price. View Analyst Ratings for CVS Health.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 5 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy."

CVS Health saw a increase in short interest in June. As of June 29th, there was short interest totalling 43,844,028 shares, an increase of 0.4% from the June 15th total of 43,662,443 shares. Based on an average trading volume of 9,965,640 shares, the short-interest ratio is presently 4.4 days. Currently, 4.3% of the company's stock are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

News stories about CVS stock have trended somewhat positive this week, according to Accern Sentiment. The research group identifies negative and positive media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. CVS Health earned a coverage optimism score of 0.16 on Accern's scale. They also gave news stories about the pharmacy operator an impact score of 43.72 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Bank of Montreal Can (0.40%), Swedbank (0.20%), Hexavest Inc. (0.13%), DnB Asset Management AS (0.12%), Gateway Investment Advisers LLC (0.06%) and Cortland Associates Inc. MO (0.05%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, NN Investment Partners Holdings N.V., DnB Asset Management AS, Swedbank, Gateway Investment Advisers LLC, Welch & Forbes LLC, Union Bankshares Corp and State of Alaska Department of Revenue. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Lisa Bisaccia, Richard J Swift and Thomas M Moriarty. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Adams Asset Advisors LLC, TNB Financial, Addenda Capital Inc., Farmers Trust Co., CX Institutional, Cacti Asset Management LLC and Rockland Trust Co.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $68.24.

CVS Health has a market capitalization of $69.77 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]